This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Compare Glide Path and Equal Weight strategies to understand which fits your retirement goals. Learn key differences, risks, and practical steps to apply in your portfolio.
26,443 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Bitcoin steadied after news of new U.S. strikes in Iran. Analysts say the move was conditionally priced, setting up a...
This week brought a sharp turn for Zscaler investors. Despite beating earnings estimates, the stock moved lower as gu...
XRP hit a 19-month low this week, rattling investors. Traders are watching for a ripple bounce back after potential c...
The Federal Reserve again left its policy rate at 3.75% on June 17, 2026, signaling patience as inflation cools but m...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...
Legislation on the CLARITY Act moves toward a pivotal Senate floor vote, even as law-enforcement groups push back on ...
For dividend kings long-term investors, a disciplined, income-forward approach can power wealth over two decades. Thi...
SpaceX's public debut sparked wide debate. This guide explains what a $2,000 investment could look like under differe...
A 76-year-old retiree doubles a spouse’s 401(k) via rollover, drawing attention to how your spouse kinds benefits can...
Intel stock has moved faster than its turnaround plan in many eyes. As Lip-Bu Tan reshapes the company, investors mus...
Celsius Holdings delivered a blowout Q4 and full-year results, sending shares higher as revenue accelerates and margi...